Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Joint Bone Spine|February 23, 2002
Discovery of TNF-alpha as a therapeutic target in rheumatoid arthritis: preclinical and clinical studiesMarc Feldmann, Ravinder N MainiArthritis Research|July 12, 2002
How does infliximab work in rheumatoid arthritis?Ravinder N Maini, Marc FeldmannJournal of Immunology (Baltimore, Md. : 1950)|July 6, 2010
Anti-TNF therapy, from rationale to standard of care: what lessons has it taught us?Marc Feldmann, Ravinder N MainiImmunological Reviews|July 11, 2008
Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeuticsMarc Feldmann, Sir Ravinder N MainiArthritis Research & Therapy|August 11, 2006
Interleukin-6: a new therapeutic targetJosef S Smolen, Ravinder N MainiCytokine & Growth Factor Reviews|September 11, 2002
Cytokines and anti-cytokine biologicals in autoimmunity: present and futureEvangelos T Andreakos, Brian M Foxwell, Fionula M Brennan, et al.Best Practice & Research. Clinical Rheumatology|May 5, 2004
The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritisMarc Feldmann, Fionula M Brennan, Richard O Williams, et al.Novartis Foundation Symposium|March 19, 2004
Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease?Marc Feldmann, Fionula M Brennan, Ewa Paleolog, et al.Arthritis and Rheumatism|February 2, 2008
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alphaMichael J Elliot, Ravinder N Maini, Marc Feldmann, et al.Arthritis and Rheumatism|March 2, 2006
Infliximab treatment maintains employability in patients with early rheumatoid arthritisJosef S Smolen, Chenglong Han, Désirée van der Heijde, et al.Pageof 2